Thomas J. Sebo

18.3k total citations · 2 hit papers
206 papers, 12.3k citations indexed

About

Thomas J. Sebo is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Thomas J. Sebo has authored 206 papers receiving a total of 12.3k indexed citations (citations by other indexed papers that have themselves been cited), including 104 papers in Pulmonary and Respiratory Medicine, 82 papers in Surgery and 45 papers in Oncology. Recurrent topics in Thomas J. Sebo's work include Prostate Cancer Treatment and Research (41 papers), Prostate Cancer Diagnosis and Treatment (35 papers) and Bladder and Urothelial Cancer Treatments (27 papers). Thomas J. Sebo is often cited by papers focused on Prostate Cancer Treatment and Research (41 papers), Prostate Cancer Diagnosis and Treatment (35 papers) and Bladder and Urothelial Cancer Treatments (27 papers). Thomas J. Sebo collaborates with scholars based in United States, Canada and Japan. Thomas J. Sebo's co-authors include Horst Zincke, Michael L. Blute, John C. Cheville, Christine M. Lohse, Eugene D. Kwon, Benjamin R. Kipp, Bradley C. Leibovich, Kevin C. Halling, Jean E. Lewis and Kerry D. Olsen and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Gastroenterology.

In The Last Decade

Thomas J. Sebo

205 papers receiving 12.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Tumor B7-H1 Is Associated with Poor Prognosis in Renal Cell Carcinoma Patients with Long-term Follow-up

2006 696 citations R. Houston Thompson, Susan M. Kuntz et al. Cancer Research profile →
Papillary thyroid microcarcinoma: A study of 900 cases observed in a 60-year period

2008 578 citations Bryan McIver, Clive S. Grant et al. profile →

Peers

Countries citing papers authored by Thomas J. Sebo

Since Specialization

Citations

This map shows the geographic impact of Thomas J. Sebo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas J. Sebo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas J. Sebo more than expected).

Fields of papers citing papers by Thomas J. Sebo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas J. Sebo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas J. Sebo. The network helps show where Thomas J. Sebo may publish in the future.

Co-authorship network of co-authors of Thomas J. Sebo

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas J. Sebo. A scholar is included among the top collaborators of Thomas J. Sebo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas J. Sebo. Thomas J. Sebo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	p300 Acetyltransferase Regulates Androgen Receptor Degradation and PTEN-Deficient Prostate Tumorigenesis 2014 ·Cancer Research ·Jian Zhong, Liya Ding, Laura R. Bohrer, Yunqian Pan, Ping Liu, Jun Zhang, Thomas J. Sebo, R. Jeffrey Karnes, Donald J. Tindall, Jan van Deursen, Haojie Huang	80
2	Gleason grading after neoadjuvant hormonal therapy retains prognostic value for systemic progression following radical prostatectomy 2014 ·Prostate Cancer and Prostatic Diseases ·Suzanne Stewart, John C. Cheville, Thomas J. Sebo, Igor Frank, Stephen A. Boorjian, R. Houston Thompson, Matthew T. Gettman, Matthew K. Tollefson, (unknown), Sarah P. Psutka, Eric J. Bergstralh, Laureano J. Rangel, R. Jeffrey Karnes	7
3	DoesBRAFV600E Mutation Predict Aggressive Features in Papillary Thyroid Cancer? Results From Four Endocrine Surgery Centers 2013 ·The Journal of Clinical Endocrinology & Metabolism ·Carol Li, Patricia Aragon Han, Kathleen C. Lee, (unknown), Amy Fox, Toni Beninato, (unknown), Benzon M. Dy, Thomas J. Sebo, Geoffrey B. Thompson, Clive S. Grant, Thomas J. Giordano, Paul G. Gauger, Gerard M. Doherty, Thomas J. Fahey, Justin A. Bishop, James R. Eshleman, Christopher B. Umbricht, Eric B. Schneider, Martha A. Zeiger	46
4	Invasive Fibrous Thyroiditis (Riedel Thyroiditis): The Mayo Clinic Experience, 1976–2008 2011 ·Thyroid ·Mitra M. Fatourechi, Ian Hay, Bryan McIver, Thomas J. Sebo, Vahab Fatourechi	77
5	Cystic change in thyroid carcinoma: Prevalence and estimated volume in 360 carcinomas 2010 ·Journal of Clinical Ultrasound ·Tara L. Henrichsen, Carl C. Reading, J. William Charboneau, Daniel J. Donovan, Thomas J. Sebo, Ian Hay	38
6	Quantitative Fluorescence in Situ Hybridization and its Ability to Predict Bladder Cancer Recurrence and Progression to Muscle-Invasive Bladder Cancer 2009 ·Journal of Molecular Diagnostics ·Benjamin R. Kipp, Mihaela Tănăsescu, (unknown), Sandra C. Bryant, R. Jeffrey Karnes, Thomas J. Sebo, Kevin C. Halling	24
7	Prospective Evaluation of Advanced Molecular Markers and Imaging Techniques in Patients With Indeterminate Bile Duct Strictures 2008 ·The American Journal of Gastroenterology ·Michael J. Levy, Todd H. Baron, Amy C. Clayton, Felicity Enders, Christopher J. Gostout, Kevin C. Halling, Benjamin R. Kipp, Bret T. Petersen, Lewis R. Roberts, Ashwin Rumalla, Thomas J. Sebo, Mark Topazian, Maurits J. Wiersema, Gregory J. Gores	135
8	Adenosquamous Carcinoma of the Pancreas: A Single-Institution Experience Comparing Resection and Palliative Care 2008 ·Journal of the American College of Surgeons ·Rory L. Smoot, Lizhi Zhang, Thomas J. Sebo, Florencia G. Que	40
9	A comparison of conventional cytology, DNA ploidy analysis, and fluorescence in situ hybridization for the detection of dysplasia and adenocarcinoma in patients with Barrett's esophagus 2008 ·Human Pathology ·Emily G. Barr Fritcher, Shannon M. Brankley, Benjamin R. Kipp, Jesse S. Voss, Michael B. Campion, Larry E. Morrison, Mona S. Legator, Lori S. Lutzke, Kenneth K. Wang, Thomas J. Sebo, Kevin C. Halling	45
10	B7-H3 Ligand Expression by Prostate Cancer: A Novel Marker of Prognosis and Potential Target for Therapy 2007 ·Cancer Research ·Timothy J. Roth, Yuri Sheinin, Christine M. Lohse, Susan M. Kuntz, Xavier Frigola, Brant A. Inman, Amy E. Krambeck, (unknown), R. Jeffrey Karnes, Michael L. Blute, John C. Cheville, Thomas J. Sebo, Eugene D. Kwon	204
11	Pathobiology of Pituitary Adenomas and Carcinomas 2006 ·Neurosurgery ·Bernd W. Scheithauer, Thomas A. Gaffey, Ricardo V. Lloyd, Thomas J. Sebo, Kálmán Kovács, Éva Horváth, (unknown), William F. Young, Fredric B. Meyer, (unknown), Darren Riehle, Edward R. Laws	185
12	Conventional assessment of needle biopsy specimens is more useful than digital image analysis of proliferation and DNA ploidy in prediction of positive surgical margins at radical prostatectomy 2006 ·Urology ·Shomik Sengupta, John C. Cheville, Christine M. Lohse, Horst Zincke, Robert P. Myers, Darren Riehle, V. Shane Pankratz, Michael L. Blute, Thomas J. Sebo	4
13	HER-2/neu overexpression and hormone dependency in endometrial cancer: analysis of cohort and review of literature. 2005 ·PubMed ·Andrea Mariani, Thomas J. Sebo, Jerry A. Katzmann, Darren Riehle, Sean C. Dowdy, Gary L. Keeney, Timothy G. Lesnick, Karl C. Podratz	20
14	DNA Abnormalities as Marker of Risk for Progression of Barrett's Esophagus to Adenocarcinoma: Image Cytometric DNA Analysis in Formalin-Fixed Tissues 2004 ·The American Journal of Gastroenterology ·Ming Fang, (unknown), Michael A. Klein, Thomas J. Sebo, (unknown), Raj K. Goyal	56
15	An Analysis of the p63/a-Methylacyl Coenzyme A Racemase Immunohistochemical Cocktail Stain in Prostate Needle Biopsy Specimens and Tissue Microarrays 2004 ·American Journal of Clinical Pathology ·Schuyler O. Sanderson, Thomas J. Sebo, Linda M. Murphy, Roxann M. Neumann, Jeff Slezak, John C. Cheville	31
16	p300 in prostate cancer proliferation and progression. 2003 ·PubMed ·José D. Debes, Thomas J. Sebo, Christine M. Lohse, Linda M. Murphy, (unknown), Donald J. Tindall	169
17	pT1 clear cell renal cell carcinoma 2002 ·Cancer ·John C. Cheville, Horst Zincke, Christine M. Lohse, Thomas J. Sebo, Darren Riehle, Amy L. Weaver, Michael L. Blute	25
18	Carcinoma ex pleomorphic adenoma: Pathologic analysis of 73 cases 2001 ·Human Pathology ·Jean E. Lewis, Kerry D. Olsen, Thomas J. Sebo	259
19	Improved Diagnostic Yield of Endoscopic Biliary Brush Cytology by Digital Image Analysis 2001 ·Mayo Clinic Proceedings ·Ashwin Rumalla, Todd H. Baron, Olga Leontovich, Lawrence J. Burgart, Robert F. Yacavone, Terry M. Therneau, Piet C. de Groen, Thomas J. Sebo	57
20	Factors That Influence the Measurement of Prostate Cancer DNA Ploidy and Proliferation in Paraffin Embedded Tissue Evaluated by Flow Cytometry 2001 ·Modern Pathology ·(unknown), John C. Cheville, Jerry A. Katzmann, Darren Riehle, Christine M. Lohse, V. Shane Pankratz, Thomas J. Sebo	14

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact